Analysis: There are still three groups of trapped bitcoin holders above, with the most recent trapped positions at $88,880
BlockBeats News, May 7, according to CryptoQuant data, Bitcoin is currently holding steady at $80,000, but three groups of locked-in holders remain above this price, forming effective resistance.
3–6 months realized price: $88,880 — the first overhead resistance ceiling;
12–18 months realized price: $93,450 — the second wall;
6–12 months realized price: $111,850 — the heaviest resistance, 29% higher than the current price.
Analysis points out that for Bitcoin to confirm the bottom, the price needs to break through and hold above $88,880. Only then can the most recent group of holders return to profit and relieve the first layer of selling pressure.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Offshore oil and gas module equipment company VME (VME.US) aiming for Nasdaq listing, plans to raise up to 30 million USD
Offshore oil and gas process module and separation equipment company VME Companies has applied for an IPO on Nasdaq, aiming to raise up to $30 million, with Kingswood as the sole bookrunner.
Hypertension drug developer Retension (RTSN.US) applies for US listing, plans to raise $58 million.
U.S. hypertension drug developer Retension Pharmaceuticals filed documents with the SEC last Friday, planning to raise up to $58 million through an initial public offering (IPO).
Pfizer (PFE.US) overseas price increase gains to be shared with the U.S. government: "Most Favored Nation" contract revealed, over twenty transactions still confidential
According to reports, under a new contract with the U.S. Department of Health and Human Services, Pfizer will share higher overseas drug revenues with the United States.
Autoimmune and inflammatory disease pharmaceutical company TRex Bio (TRX.US) applies for US listing, plans to raise up to 100 millions dollars.
TRex Bio filed documents with the U.S. Securities and Exchange Commission (SEC) last Friday, intending to raise up to 100 million USD through an initial public offering (IPO).
